Vsevolod Matveev
Overview
Explore the profile of Vsevolod Matveev including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
3599
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chahine S, Alkhatib K, Arakelyan G, Buxton C, Giannarini G, Hamilton R, et al.
Eur Urol Focus
. 2024 Aug;
PMID: 39147634
Background And Objective: There are limited data on the prevalence and management of testicular germ cell tumor (TGCT) cases presenting with venous tumor thrombus (VTT). Our objectives were to describe...
2.
Matveev V, Gao X, Kopyltsov E, Luo J, Wei Q, Ye D, et al.
Asia Pac J Clin Oncol
. 2024 Jul;
20(6):738-746.
PMID: 38958195
Aim: To evaluate the efficacy and safety of triptorelin after radical prostatectomy (RP) in patients with negative lymph nodes. Methods: PRIORITI (NCT01753297) was a prospective, open-label, randomized, controlled, phase 4...
3.
Senkin S, Moody S, Diaz-Gay M, Abedi-Ardekani B, Cattiaux T, Ferreiro-Iglesias A, et al.
Nature
. 2024 May;
629(8013):910-918.
PMID: 38693263
International differences in the incidence of many cancer types indicate the existence of carcinogen exposures that have not yet been identified by conventional epidemiology make a substantial contribution to cancer...
4.
Mink J, Khalmurzaev O, Pryalukhin A, Geppert C, Lohse S, Bende K, et al.
Cancers (Basel)
. 2023 Oct;
15(19).
PMID: 37835442
Background: Advanced penile carcinoma is characterized by poor prognosis. Most data on prognostic factors are based on small study cohorts, and even meta-analyses are limited in patient numbers. Therefore, there...
5.
Mink J, Khalmurzaev O, Pryalukhin A, Holters S, Geppert C, Lohse S, et al.
Aktuelle Urol
. 2023 Aug;
54(4):274-284.
PMID: 37541236
Background: Penile cancer is a rare but often lethal tumour disease, especially in the metastatic stage. Most data on prognostic factors for penile cancer are based on small patient cohorts,...
6.
Sheikh M, Mukeriya A, Zahed H, Feng X, Robbins H, Shangina O, et al.
J Clin Oncol
. 2023 Mar;
41(15):2747-2755.
PMID: 36989465
Purpose: To investigate whether postdiagnosis smoking cessation may affect the risk of death and disease progression in patients with renal cell carcinoma (RCC) who smoked at the time of diagnosis....
7.
Apanovich N, Apanovich P, Mansorunov D, Kuzevanova A, Matveev V, Karpukhin A
Front Oncol
. 2021 May;
11:615787.
PMID: 34046336
We aimed to identify and investigate genes that are essential for the development of clear cell renal cell carcinoma (ccRCC) and sought to shed light on the mechanisms of its...
8.
Bjartell A, Lumen N, Maroto P, Paiss T, Gomez-Veiga F, Birtle A, et al.
Target Oncol
. 2021 Apr;
16(3):357-367.
PMID: 33826036
Background: Despite standard-of-care androgen-deprivation therapy and an increasing number of treatment options, the mortality rate for prostate cancer remains high. Progress to metastatic castration-resistant prostate cancer (mCRPC) necessitates additional treatments....
9.
Volkova M, Tsimafeyeu I, Olshanskaya A, Khochenkova Y, Solomko E, Ashuba S, et al.
Am J Clin Exp Urol
. 2021 Apr;
9(1):65-72.
PMID: 33816695
Background: There is the evidence of the role of the fibroblast growth factor and its receptors (FGF/FGFR) signaling pathway in tumorogenesis of renal cell carcinoma (RCC). We conducted a study...
10.
Volkova M, Tsimafeyeu I, Olshanskaya A, Khochenkova Y, Solomko E, Ashuba S, et al.
Cent European J Urol
. 2021 Feb;
73(4):466-475.
PMID: 33552572
Introduction: The aim of our study was to investigate expression levels and the prognostic value of multiple growth factors and their receptors in the primary tumor cells of renal cell...